nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—ABCB1—Topotecan—cervical cancer	0.297	0.625	CbGbCtD
Clonidine—CYP3A4—Topotecan—cervical cancer	0.178	0.375	CbGbCtD
Clonidine—NISCH—uterine cervix—cervical cancer	0.0127	0.03	CbGeAlD
Clonidine—NISCH—decidua—cervical cancer	0.0121	0.0286	CbGeAlD
Clonidine—NISCH—mammalian vulva—cervical cancer	0.0111	0.0262	CbGeAlD
Clonidine—ADRA1D—epithelium—cervical cancer	0.0107	0.0252	CbGeAlD
Clonidine—NISCH—uterus—cervical cancer	0.0106	0.025	CbGeAlD
Clonidine—ADRA1B—renal system—cervical cancer	0.0101	0.0239	CbGeAlD
Clonidine—NISCH—female gonad—cervical cancer	0.00865	0.0204	CbGeAlD
Clonidine—NISCH—vagina—cervical cancer	0.00859	0.0203	CbGeAlD
Clonidine—SLC22A4—decidua—cervical cancer	0.00799	0.0189	CbGeAlD
Clonidine—ADRA1D—female reproductive system—cervical cancer	0.00793	0.0188	CbGeAlD
Clonidine—SLC22A4—renal system—cervical cancer	0.00784	0.0186	CbGeAlD
Clonidine—SLC22A3—uterine cervix—cervical cancer	0.00763	0.018	CbGeAlD
Clonidine—SLC22A4—endometrium—cervical cancer	0.00758	0.0179	CbGeAlD
Clonidine—SLC22A1—renal system—cervical cancer	0.00747	0.0177	CbGeAlD
Clonidine—SLC22A3—renal system—cervical cancer	0.00714	0.0169	CbGeAlD
Clonidine—SLC22A3—endometrium—cervical cancer	0.0069	0.0163	CbGeAlD
Clonidine—SLC22A3—mammalian vulva—cervical cancer	0.00668	0.0158	CbGeAlD
Clonidine—SLC22A4—female reproductive system—cervical cancer	0.00628	0.0149	CbGeAlD
Clonidine—SLC6A2—decidua—cervical cancer	0.00623	0.0147	CbGeAlD
Clonidine—ADRA1A—epithelium—cervical cancer	0.00613	0.0145	CbGeAlD
Clonidine—ADRA2C—uterine cervix—cervical cancer	0.00579	0.0137	CbGeAlD
Clonidine—SLC22A3—female reproductive system—cervical cancer	0.00572	0.0135	CbGeAlD
Clonidine—ADRA1A—renal system—cervical cancer	0.00569	0.0134	CbGeAlD
Clonidine—SLC22A4—vagina—cervical cancer	0.00568	0.0134	CbGeAlD
Clonidine—NISCH—lymph node—cervical cancer	0.00556	0.0131	CbGeAlD
Clonidine—SLC22A5—uterine cervix—cervical cancer	0.00555	0.0131	CbGeAlD
Clonidine—ADRA2C—decidua—cervical cancer	0.00552	0.0131	CbGeAlD
Clonidine—ADRA2C—renal system—cervical cancer	0.00542	0.0128	CbGeAlD
Clonidine—SLC22A1—vagina—cervical cancer	0.00541	0.0128	CbGeAlD
Clonidine—ADRA2C—endometrium—cervical cancer	0.00524	0.0124	CbGeAlD
Clonidine—SLC22A3—female gonad—cervical cancer	0.0052	0.0123	CbGeAlD
Clonidine—SLC22A5—renal system—cervical cancer	0.00519	0.0123	CbGeAlD
Clonidine—SLC22A3—vagina—cervical cancer	0.00517	0.0122	CbGeAlD
Clonidine—ADRA2C—mammalian vulva—cervical cancer	0.00507	0.012	CbGeAlD
Clonidine—SLC22A5—endometrium—cervical cancer	0.00502	0.0119	CbGeAlD
Clonidine—CYP1A1—epithelium—cervical cancer	0.005	0.0118	CbGeAlD
Clonidine—CYP1A1—uterine cervix—cervical cancer	0.00496	0.0117	CbGeAlD
Clonidine—SLC6A2—female reproductive system—cervical cancer	0.0049	0.0116	CbGeAlD
Clonidine—CYP3A5—uterine cervix—cervical cancer	0.00485	0.0115	CbGeAlD
Clonidine—ADRA2C—uterus—cervical cancer	0.00483	0.0114	CbGeAlD
Clonidine—Respiratory failure—Topotecan—cervical cancer	0.00474	0.0508	CcSEcCtD
Clonidine—CYP1A2—renal system—cervical cancer	0.0047	0.0111	CbGeAlD
Clonidine—CYP1A1—renal system—cervical cancer	0.00464	0.011	CbGeAlD
Clonidine—ADRA2A—uterine cervix—cervical cancer	0.00462	0.0109	CbGeAlD
Clonidine—CYP3A5—renal system—cervical cancer	0.00454	0.0107	CbGeAlD
Clonidine—ADRA2A—decidua—cervical cancer	0.0044	0.0104	CbGeAlD
Clonidine—CYP1A1—mammalian vulva—cervical cancer	0.00434	0.0103	CbGeAlD
Clonidine—Rash maculo-papular—Topotecan—cervical cancer	0.00423	0.0454	CcSEcCtD
Clonidine—ADRA2A—endometrium—cervical cancer	0.00418	0.00989	CbGeAlD
Clonidine—SLC22A5—female reproductive system—cervical cancer	0.00416	0.00983	CbGeAlD
Clonidine—CYP1A1—uterus—cervical cancer	0.00413	0.00977	CbGeAlD
Clonidine—ADRA2A—mammalian vulva—cervical cancer	0.00404	0.00956	CbGeAlD
Clonidine—Ear pain—Topotecan—cervical cancer	0.00396	0.0425	CcSEcCtD
Clonidine—ADRA2C—female gonad—cervical cancer	0.00395	0.00934	CbGeAlD
Clonidine—ADRA2C—vagina—cervical cancer	0.00393	0.00928	CbGeAlD
Clonidine—ADRA2A—uterus—cervical cancer	0.00385	0.00911	CbGeAlD
Clonidine—SLC22A5—female gonad—cervical cancer	0.00378	0.00895	CbGeAlD
Clonidine—SLC22A5—vagina—cervical cancer	0.00376	0.00889	CbGeAlD
Clonidine—CYP1A1—female reproductive system—cervical cancer	0.00371	0.00879	CbGeAlD
Clonidine—SLC22A4—lymph node—cervical cancer	0.00367	0.00869	CbGeAlD
Clonidine—ADRA2A—female reproductive system—cervical cancer	0.00346	0.00819	CbGeAlD
Clonidine—Lethargy—Topotecan—cervical cancer	0.00345	0.037	CcSEcCtD
Clonidine—CYP3A4—renal system—cervical cancer	0.0034	0.00805	CbGeAlD
Clonidine—CYP1A1—female gonad—cervical cancer	0.00338	0.00799	CbGeAlD
Clonidine—CYP1A1—vagina—cervical cancer	0.00336	0.00795	CbGeAlD
Clonidine—CYP2D6—renal system—cervical cancer	0.00335	0.00792	CbGeAlD
Clonidine—SLC22A3—lymph node—cervical cancer	0.00334	0.00791	CbGeAlD
Clonidine—CYP3A5—female gonad—cervical cancer	0.00331	0.00782	CbGeAlD
Clonidine—CYP3A5—vagina—cervical cancer	0.00329	0.00777	CbGeAlD
Clonidine—ADRA2A—female gonad—cervical cancer	0.00315	0.00745	CbGeAlD
Clonidine—ADRA2A—vagina—cervical cancer	0.00313	0.00741	CbGeAlD
Clonidine—Cramp muscle—Topotecan—cervical cancer	0.00304	0.0326	CcSEcCtD
Clonidine—SLC6A2—lymph node—cervical cancer	0.00287	0.00678	CbGeAlD
Clonidine—CYP3A4—female reproductive system—cervical cancer	0.00273	0.00645	CbGeAlD
Clonidine—CYP2D6—female reproductive system—cervical cancer	0.00268	0.00634	CbGeAlD
Clonidine—Weight increased—Topotecan—cervical cancer	0.00266	0.0285	CcSEcCtD
Clonidine—ABCB1—epithelium—cervical cancer	0.0026	0.00614	CbGeAlD
Clonidine—ABCB1—uterine cervix—cervical cancer	0.00258	0.00609	CbGeAlD
Clonidine—ADRA2C—lymph node—cervical cancer	0.00254	0.006	CbGeAlD
Clonidine—Sweating—Topotecan—cervical cancer	0.0025	0.0268	CcSEcCtD
Clonidine—Epistaxis—Topotecan—cervical cancer	0.00246	0.0263	CcSEcCtD
Clonidine—ABCB1—decidua—cervical cancer	0.00245	0.0058	CbGeAlD
Clonidine—CYP2D6—female gonad—cervical cancer	0.00244	0.00577	CbGeAlD
Clonidine—SLC22A5—lymph node—cervical cancer	0.00243	0.00575	CbGeAlD
Clonidine—ABCB1—renal system—cervical cancer	0.00241	0.0057	CbGeAlD
Clonidine—Rhinitis—Topotecan—cervical cancer	0.00234	0.0251	CcSEcCtD
Clonidine—ABCB1—endometrium—cervical cancer	0.00233	0.00551	CbGeAlD
Clonidine—Hypoaesthesia—Topotecan—cervical cancer	0.00232	0.0249	CcSEcCtD
Clonidine—ABCB1—mammalian vulva—cervical cancer	0.00225	0.00533	CbGeAlD
Clonidine—CYP1A1—lymph node—cervical cancer	0.00217	0.00514	CbGeAlD
Clonidine—ABCB1—uterus—cervical cancer	0.00215	0.00508	CbGeAlD
Clonidine—Angiopathy—Topotecan—cervical cancer	0.00212	0.0227	CcSEcCtD
Clonidine—Mediastinal disorder—Topotecan—cervical cancer	0.00211	0.0226	CcSEcCtD
Clonidine—Alopecia—Topotecan—cervical cancer	0.00206	0.0222	CcSEcCtD
Clonidine—ADRA2A—lymph node—cervical cancer	0.00203	0.00479	CbGeAlD
Clonidine—Muscle spasms—Topotecan—cervical cancer	0.00196	0.021	CcSEcCtD
Clonidine—ABCB1—female reproductive system—cervical cancer	0.00193	0.00456	CbGeAlD
Clonidine—Ill-defined disorder—Topotecan—cervical cancer	0.00189	0.0203	CcSEcCtD
Clonidine—Angioedema—Topotecan—cervical cancer	0.00186	0.0199	CcSEcCtD
Clonidine—Malaise—Topotecan—cervical cancer	0.00183	0.0197	CcSEcCtD
Clonidine—Cough—Topotecan—cervical cancer	0.00178	0.019	CcSEcCtD
Clonidine—ABCB1—female gonad—cervical cancer	0.00176	0.00415	CbGeAlD
Clonidine—ABCB1—vagina—cervical cancer	0.00175	0.00413	CbGeAlD
Clonidine—Chest pain—Topotecan—cervical cancer	0.00173	0.0186	CcSEcCtD
Clonidine—Arthralgia—Topotecan—cervical cancer	0.00173	0.0186	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.00172	0.0185	CcSEcCtD
Clonidine—Discomfort—Topotecan—cervical cancer	0.00171	0.0184	CcSEcCtD
Clonidine—Infection—Topotecan—cervical cancer	0.00165	0.0177	CcSEcCtD
Clonidine—Nervous system disorder—Topotecan—cervical cancer	0.00163	0.0175	CcSEcCtD
Clonidine—Thrombocytopenia—Topotecan—cervical cancer	0.00163	0.0174	CcSEcCtD
Clonidine—Skin disorder—Topotecan—cervical cancer	0.00161	0.0173	CcSEcCtD
Clonidine—Hyperhidrosis—Topotecan—cervical cancer	0.0016	0.0172	CcSEcCtD
Clonidine—Anorexia—Topotecan—cervical cancer	0.00158	0.017	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00151	0.0162	CcSEcCtD
Clonidine—Paraesthesia—Topotecan—cervical cancer	0.00149	0.016	CcSEcCtD
Clonidine—Dyspnoea—Topotecan—cervical cancer	0.00148	0.0159	CcSEcCtD
Clonidine—Decreased appetite—Topotecan—cervical cancer	0.00144	0.0155	CcSEcCtD
Clonidine—Gastrointestinal disorder—Topotecan—cervical cancer	0.00143	0.0154	CcSEcCtD
Clonidine—Fatigue—Topotecan—cervical cancer	0.00143	0.0154	CcSEcCtD
Clonidine—Pain—Topotecan—cervical cancer	0.00142	0.0152	CcSEcCtD
Clonidine—Constipation—Topotecan—cervical cancer	0.00142	0.0152	CcSEcCtD
Clonidine—Feeling abnormal—Topotecan—cervical cancer	0.00137	0.0147	CcSEcCtD
Clonidine—Gastrointestinal pain—Topotecan—cervical cancer	0.00136	0.0146	CcSEcCtD
Clonidine—Urticaria—Topotecan—cervical cancer	0.00132	0.0142	CcSEcCtD
Clonidine—Abdominal pain—Topotecan—cervical cancer	0.00131	0.0141	CcSEcCtD
Clonidine—Body temperature increased—Topotecan—cervical cancer	0.00131	0.0141	CcSEcCtD
Clonidine—Hypersensitivity—Topotecan—cervical cancer	0.00122	0.0131	CcSEcCtD
Clonidine—Asthenia—Topotecan—cervical cancer	0.00119	0.0128	CcSEcCtD
Clonidine—Pruritus—Topotecan—cervical cancer	0.00117	0.0126	CcSEcCtD
Clonidine—Diarrhoea—Topotecan—cervical cancer	0.00114	0.0122	CcSEcCtD
Clonidine—ABCB1—lymph node—cervical cancer	0.00113	0.00267	CbGeAlD
Clonidine—Dizziness—Topotecan—cervical cancer	0.0011	0.0118	CcSEcCtD
Clonidine—Vomiting—Topotecan—cervical cancer	0.00106	0.0113	CcSEcCtD
Clonidine—Rash—Topotecan—cervical cancer	0.00105	0.0112	CcSEcCtD
Clonidine—Dermatitis—Topotecan—cervical cancer	0.00105	0.0112	CcSEcCtD
Clonidine—Headache—Topotecan—cervical cancer	0.00104	0.0112	CcSEcCtD
Clonidine—Nausea—Topotecan—cervical cancer	0.000986	0.0106	CcSEcCtD
Clonidine—ADRA2B—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.000509	0.0557	CbGpPWpGaD
Clonidine—ADRA2C—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.000476	0.052	CbGpPWpGaD
Clonidine—ADRA1D—Amine ligand-binding receptors—TAAR6—cervical cancer	0.000394	0.043	CbGpPWpGaD
Clonidine—ADRA2A—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.000386	0.0422	CbGpPWpGaD
Clonidine—ADRA2B—Amine ligand-binding receptors—TAAR6—cervical cancer	0.000356	0.0389	CbGpPWpGaD
Clonidine—ADRA2C—Amine ligand-binding receptors—TAAR6—cervical cancer	0.000332	0.0363	CbGpPWpGaD
Clonidine—ADRA1B—Amine ligand-binding receptors—TAAR6—cervical cancer	0.000327	0.0357	CbGpPWpGaD
Clonidine—ADRA1A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00029	0.0317	CbGpPWpGaD
Clonidine—ADRA2A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.00027	0.0295	CbGpPWpGaD
Clonidine—ADRA1D—G alpha (12/13) signalling events—AKAP13—cervical cancer	0.000167	0.0182	CbGpPWpGaD
Clonidine—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	0.000164	0.0179	CbGpPWpGaD
Clonidine—ADRA2B—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.000139	0.0152	CbGpPWpGaD
Clonidine—ADRA1B—G alpha (12/13) signalling events—AKAP13—cervical cancer	0.000138	0.0151	CbGpPWpGaD
Clonidine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000136	0.0148	CbGpPWpGaD
Clonidine—ADRA2C—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00013	0.0142	CbGpPWpGaD
Clonidine—ADRA1A—G alpha (12/13) signalling events—AKAP13—cervical cancer	0.000123	0.0134	CbGpPWpGaD
Clonidine—ADRA2B—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000122	0.0133	CbGpPWpGaD
Clonidine—ADRA2C—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000114	0.0124	CbGpPWpGaD
Clonidine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000108	0.0119	CbGpPWpGaD
Clonidine—ADRA2A—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.000106	0.0116	CbGpPWpGaD
Clonidine—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000104	0.0114	CbGpPWpGaD
Clonidine—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	9.4e-05	0.0103	CbGpPWpGaD
Clonidine—ADRA2A—Platelet activation, signaling and aggregation—GP5—cervical cancer	9.25e-05	0.0101	CbGpPWpGaD
Clonidine—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	8.71e-05	0.00952	CbGpPWpGaD
Clonidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	8.37e-05	0.00915	CbGpPWpGaD
Clonidine—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	8.06e-05	0.00881	CbGpPWpGaD
Clonidine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	7.75e-05	0.00847	CbGpPWpGaD
Clonidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	7.25e-05	0.00793	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—GP6—cervical cancer	7.19e-05	0.00786	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—SERPIND1—cervical cancer	7.19e-05	0.00786	CbGpPWpGaD
Clonidine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	6.99e-05	0.00764	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—SERPIND1—cervical cancer	6.72e-05	0.00734	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—GP6—cervical cancer	6.72e-05	0.00734	CbGpPWpGaD
Clonidine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	6.53e-05	0.00714	CbGpPWpGaD
Clonidine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	6.43e-05	0.00703	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—GP5—cervical cancer	6.28e-05	0.00687	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—TAAR6—cervical cancer	5.9e-05	0.00645	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—GP5—cervical cancer	5.87e-05	0.00642	CbGpPWpGaD
Clonidine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	5.71e-05	0.00624	CbGpPWpGaD
Clonidine—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	5.56e-05	0.00607	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—GP6—cervical cancer	5.45e-05	0.00596	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—SERPIND1—cervical cancer	5.45e-05	0.00596	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—TAAR6—cervical cancer	5.33e-05	0.00582	CbGpPWpGaD
Clonidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	5.31e-05	0.0058	CbGpPWpGaD
Clonidine—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	5.07e-05	0.00554	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—TAAR6—cervical cancer	4.97e-05	0.00544	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—TAAR6—cervical cancer	4.9e-05	0.00535	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—GP5—cervical cancer	4.77e-05	0.00521	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	4.62e-05	0.00505	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—WNT2—cervical cancer	4.61e-05	0.00503	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—TAAR6—cervical cancer	4.35e-05	0.00475	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—WNT2—cervical cancer	4.16e-05	0.00454	CbGpPWpGaD
Clonidine—ADRA1B—AMPK Signaling—MTOR—cervical cancer	4.15e-05	0.00454	CbGpPWpGaD
Clonidine—ADRA1B—LPA receptor mediated events—CASP3—cervical cancer	4.06e-05	0.00443	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—TAAR6—cervical cancer	4.04e-05	0.00442	CbGpPWpGaD
Clonidine—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	3.96e-05	0.00433	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—WNT2—cervical cancer	3.88e-05	0.00425	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—WNT2—cervical cancer	3.82e-05	0.00418	CbGpPWpGaD
Clonidine—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	3.8e-05	0.00416	CbGpPWpGaD
Clonidine—ADRA1A—AMPK Signaling—MTOR—cervical cancer	3.69e-05	0.00403	CbGpPWpGaD
Clonidine—ADRA1D—GPCR ligand binding—WNT5A—cervical cancer	3.49e-05	0.00381	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	3.41e-05	0.00373	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—WNT2—cervical cancer	3.4e-05	0.00371	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—TAAR6—cervical cancer	3.33e-05	0.00364	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—WNT2—cervical cancer	3.15e-05	0.00345	CbGpPWpGaD
Clonidine—ADRA2B—GPCR ligand binding—WNT5A—cervical cancer	3.15e-05	0.00344	CbGpPWpGaD
Clonidine—ADRA1B—LPA receptor mediated events—EGFR—cervical cancer	3.1e-05	0.00338	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—TAAR6—cervical cancer	3.03e-05	0.00331	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—TAAR6—cervical cancer	3.01e-05	0.00329	CbGpPWpGaD
Clonidine—ADRA2C—GPCR ligand binding—WNT5A—cervical cancer	2.94e-05	0.00322	CbGpPWpGaD
Clonidine—ADRA1B—GPCR ligand binding—WNT5A—cervical cancer	2.9e-05	0.00317	CbGpPWpGaD
Clonidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	2.88e-05	0.00315	CbGpPWpGaD
Clonidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	2.88e-05	0.00315	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—TAAR6—cervical cancer	2.81e-05	0.00307	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—TAAR6—cervical cancer	2.77e-05	0.00302	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—TAAR6—cervical cancer	2.73e-05	0.00299	CbGpPWpGaD
Clonidine—ABCB1—Allograft Rejection—CASP8—cervical cancer	2.58e-05	0.00282	CbGpPWpGaD
Clonidine—ADRA1A—GPCR ligand binding—WNT5A—cervical cancer	2.57e-05	0.00281	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—TAAR6—cervical cancer	2.55e-05	0.00279	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—TAAR6—cervical cancer	2.51e-05	0.00275	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—TAAR6—cervical cancer	2.46e-05	0.00269	CbGpPWpGaD
Clonidine—ADRA1B—AMPK Signaling—TP53—cervical cancer	2.45e-05	0.00268	CbGpPWpGaD
Clonidine—ADRA2A—GPCR ligand binding—WNT5A—cervical cancer	2.39e-05	0.00261	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—WNT2—cervical cancer	2.36e-05	0.00258	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKAP13—cervical cancer	2.28e-05	0.0025	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—TAAR6—cervical cancer	2.28e-05	0.0025	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—TAAR6—cervical cancer	2.23e-05	0.00244	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—CA9—cervical cancer	2.18e-05	0.00238	CbGpPWpGaD
Clonidine—ADRA1A—AMPK Signaling—TP53—cervical cancer	2.17e-05	0.00238	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—WNT2—cervical cancer	2.13e-05	0.00233	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKAP13—cervical cancer	2.07e-05	0.00227	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—TAAR6—cervical cancer	2.07e-05	0.00227	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKAP13—cervical cancer	2.06e-05	0.00225	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—WNT2—cervical cancer	1.99e-05	0.00218	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—WNT2—cervical cancer	1.96e-05	0.00214	CbGpPWpGaD
Clonidine—ABCB1—Allograft Rejection—CASP3—cervical cancer	1.96e-05	0.00214	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKAP13—cervical cancer	1.93e-05	0.00211	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKAP13—cervical cancer	1.9e-05	0.00207	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKAP13—cervical cancer	1.87e-05	0.00205	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	1.84e-05	0.00201	CbGpPWpGaD
Clonidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	1.84e-05	0.00201	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—WNT5A—cervical cancer	1.79e-05	0.00196	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TAAR6—cervical cancer	1.79e-05	0.00195	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKAP13—cervical cancer	1.75e-05	0.00191	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—WNT2—cervical cancer	1.74e-05	0.0019	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKAP13—cervical cancer	1.72e-05	0.00188	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKAP13—cervical cancer	1.68e-05	0.00184	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	1.62e-05	0.00177	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—WNT5A—cervical cancer	1.62e-05	0.00177	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TAAR6—cervical cancer	1.61e-05	0.00176	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	1.57e-05	0.00171	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKAP13—cervical cancer	1.53e-05	0.00167	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—WNT5A—cervical cancer	1.51e-05	0.00165	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TAAR6—cervical cancer	1.51e-05	0.00165	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—WNT5A—cervical cancer	1.49e-05	0.00162	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TAAR6—cervical cancer	1.48e-05	0.00162	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	1.42e-05	0.00155	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	1.42e-05	0.00155	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—WNT2—cervical cancer	1.4e-05	0.00153	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—CA9—cervical cancer	1.33e-05	0.00145	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	1.32e-05	0.00144	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	1.32e-05	0.00144	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.28e-05	0.00139	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—CA9—cervical cancer	1.27e-05	0.00139	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—WNT2—cervical cancer	1.26e-05	0.00138	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	1.23e-05	0.00134	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKAP13—cervical cancer	1.23e-05	0.00134	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	1.22e-05	0.00134	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—WNT2—cervical cancer	1.18e-05	0.00129	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	1.17e-05	0.00128	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—WNT2—cervical cancer	1.16e-05	0.00127	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKAP13—cervical cancer	1.11e-05	0.00121	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—CA9—cervical cancer	1.08e-05	0.00118	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	1.06e-05	0.00116	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	1.04e-05	0.00114	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKAP13—cervical cancer	1.03e-05	0.00113	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—WNT2—cervical cancer	1.03e-05	0.00113	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	1.02e-05	0.00111	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—CA9—cervical cancer	9.9e-06	0.00108	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	9.65e-06	0.00105	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—WNT2—cervical cancer	9.56e-06	0.00105	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—WNT5A—cervical cancer	9.55e-06	0.00104	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—CA9—cervical cancer	9.35e-06	0.00102	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	9.3e-06	0.00102	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	9.04e-06	0.000988	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—WNT5A—cervical cancer	8.92e-06	0.000975	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—MTHFR—cervical cancer	8.85e-06	0.000967	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	8.78e-06	0.00096	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	8.4e-06	0.000918	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	7.8e-06	0.000853	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CA9—cervical cancer	7.47e-06	0.000816	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	7.43e-06	0.000812	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	7.37e-06	0.000806	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	7.25e-06	0.000792	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CA9—cervical cancer	7.04e-06	0.000769	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	6.7e-06	0.000733	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	6.26e-06	0.000685	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	6.19e-06	0.000676	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	6.16e-06	0.000674	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HES1—cervical cancer	6.09e-06	0.000666	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CA9—cervical cancer	5.96e-06	0.000652	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HES1—cervical cancer	5.5e-06	0.000601	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	5.47e-06	0.000598	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—cervical cancer	5.41e-06	0.000591	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—MTHFR—cervical cancer	5.4e-06	0.00059	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TERT—cervical cancer	5.34e-06	0.000583	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—MTHFR—cervical cancer	5.17e-06	0.000565	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HES1—cervical cancer	5.13e-06	0.000561	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	5.09e-06	0.000556	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HES1—cervical cancer	5.05e-06	0.000552	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—cervical cancer	5.05e-06	0.000552	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	4.9e-06	0.000535	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TERT—cervical cancer	4.82e-06	0.000526	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CA9—cervical cancer	4.6e-06	0.000503	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	4.6e-06	0.000502	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TERT—cervical cancer	4.5e-06	0.000492	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HES1—cervical cancer	4.49e-06	0.000491	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TERT—cervical cancer	4.43e-06	0.000484	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	4.42e-06	0.000483	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—MTHFR—cervical cancer	4.38e-06	0.000479	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HES1—cervical cancer	4.17e-06	0.000456	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	4.15e-06	0.000454	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	4.13e-06	0.000451	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—cervical cancer	4.1e-06	0.000449	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	4.1e-06	0.000448	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	4.06e-06	0.000444	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—MTHFR—cervical cancer	4.02e-06	0.000439	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TERT—cervical cancer	3.93e-06	0.00043	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	3.88e-06	0.000424	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	3.82e-06	0.000417	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—MTHFR—cervical cancer	3.79e-06	0.000415	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	3.7e-06	0.000404	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TERT—cervical cancer	3.65e-06	0.000399	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	3.61e-06	0.000395	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	3.45e-06	0.000378	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MTOR—cervical cancer	3.44e-06	0.000376	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	3.4e-06	0.000372	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	3.39e-06	0.00037	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	3.35e-06	0.000367	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CASP3—cervical cancer	3.17e-06	0.000346	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	3.15e-06	0.000344	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MTOR—cervical cancer	3.11e-06	0.00034	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	3.05e-06	0.000334	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—MTHFR—cervical cancer	3.03e-06	0.000331	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	3.02e-06	0.00033	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MTOR—cervical cancer	2.9e-06	0.000318	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—cervical cancer	2.86e-06	0.000313	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	2.86e-06	0.000312	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—MTHFR—cervical cancer	2.86e-06	0.000312	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	2.81e-06	0.000307	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	2.76e-06	0.000301	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—cervical cancer	2.67e-06	0.000292	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—cervical cancer	2.66e-06	0.000291	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	2.63e-06	0.000287	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	2.58e-06	0.000281	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	2.54e-06	0.000278	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	2.53e-06	0.000277	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MTHFR—cervical cancer	2.42e-06	0.000264	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EGFR—cervical cancer	2.42e-06	0.000264	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—cervical cancer	2.4e-06	0.000263	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	2.36e-06	0.000258	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	2.34e-06	0.000255	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	2.25e-06	0.000246	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—cervical cancer	2.24e-06	0.000245	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	2.21e-06	0.000241	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EGFR—cervical cancer	2.18e-06	0.000239	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	2.17e-06	0.000237	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	2.09e-06	0.000229	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EGFR—cervical cancer	2.04e-06	0.000223	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—cervical cancer	2.03e-06	0.000222	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	2.01e-06	0.000219	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	1.96e-06	0.000215	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MTHFR—cervical cancer	1.87e-06	0.000204	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—cervical cancer	1.83e-06	0.0002	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	1.82e-06	0.000199	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	1.78e-06	0.000195	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—cervical cancer	1.71e-06	0.000187	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—cervical cancer	1.69e-06	0.000184	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	1.66e-06	0.000181	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—cervical cancer	1.5e-06	0.000164	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—cervical cancer	1.39e-06	0.000152	CbGpPWpGaD
